Journal of Cancer Therapy

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org
"The Use of Neupogen (Filgrastim) or Neulasta (Pegfilgrastim) during Pregnancy When Chemotherapy Is Indicated for Maternal Cancer Treatment"
written by Elyce Cardonick, Farhana Irfan, Natalie Torres,
published by Journal of Cancer Therapy, Vol.3 No.2, 2012
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Effect of intra uterine granulocyte colony stimulating factor vs. human chorionic gonadotropin at ovum pick up day on pregnancy rate in IVF/ICSI cases with …
Desouky, A El-Baz, R Aly… - JBRA Assisted …, 2022
[2] Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?
Critical Reviews in …, 2022
[3] Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional …
Breast Cancer Research …, 2022
[4] Zasady postępowania w przypadku chorób nowotworowych u kobiet w ciąży
Varia …, 2021
[5] Impactul fetal şi neonatal al metodelor de diagnostic şi al chimioterapiei în sarcină la gravidele cu afecţiuni oncologice
Ginecologia. ro, 2021
[6] Pregnancy and malignant diseases—principles of management
Oncology in Clinical …, 2021
[7] Management of pregnancy in women with cancer
2021
[8] Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy
2021
[9] Comparing the efficacy and side-effects of PDLASTA®(Pegfilgrastim) with PDGRASTIM®(Filgrastim) in breast cancer patients: a non-inferiority randomized …
2021
[10] Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy. Cancers 2021, 13, 1214
2021
[11] Safe and Effective Kinase Inhibitors for the Treatment of Gynecological Cancers: In Silico Approach
2021
[12] Recherche de marqueurs prédictifs de l'implantation embryonnaire humaine
2020
[13] Cáncer de mama asociado a embarazo
2020
[14] Pregnancy associated breast cancer
2020
[15] Supportive medication in cancer during pregnancy
2020
[16] Cancer During Pregnancy: The Oncologist Overview
2019
[17] G-CSF and GM-CSF: Clinical Applications in Reproductive Medicine
2019
[18] Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer
2019
[19] Managing Cancer during Pregnancy
2019
[20] Breast cancer and Fertility Part 2-Pregnancy Associated Breast Cancer
2018
[21] A Review of Pregnancy-Associated Breast Cancer: Diagnosis, Local and Systemic Treatment, and Prognosis
2018
[22] Chemotherapy and Pregnancy
2017
[23] Multidisciplinary management of breast cancer during pregnancy
2017
[24] Cancer in pregnancy: safety and efficacy of systemic therapies
Current Opinion in Oncology, 2017
[25] Treatment of Breast Cancer During Pregnancy
Current Breast Cancer Reports, 2017
[26] Tratamiento del cáncer de mama diagnosticado durante el embarazo
2017
[27] Cancer Treatment in Pregnancy
Cancer and Fertility, 2016
[28] Supportive Care During Pregnancy
Managing Cancer during Pregnancy, 2016
[29] Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions
Journal of reproductive immunology, 2015
[30] Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients
JAMA oncology, 2015
[31] Breast cancer in pregnancy: A brief clinical review
Best Practice & Research Clinical Obstetrics & Gynaecology, 2015
[32] Pregnancy-associated breast cancer: optimal treatment options
International journal of women's health, 2014
[33] Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy
Obstetrics & Gynecology, 2012
[34] Comparing the E cacy and Side Effects of PDLASTA®(Peg-Filgrastim) with PDGRASTIM®(Filgrastim) in Breast Cancer Patients; A Non-inferiority Randomized …
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top